Who to call at HeartSciences Inc., and when
Fundz watches for the moments HeartSciences Inc. starts buying, and tells you who to reach.
- An alert the day HeartSciences Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HeartSciences Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HeartSciences Inc.. With Fundz connected, it knows.
HeartSciences Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
heartsciences.comAI Executive Summary
AI-powered analysis of 8-K filing content
HeartSciences' Board approved Amendment No. 3 to its 2023 Equity Incentive Plan, raising the share reserve to 1,250,000 shares and granting restricted shares and RSUs to executive officers, including 70,000 shares to the CEO. The plan amendment requires shareholder approval at the next annual meeting and includes an evergreen increase starting May 1, 2026, which expands potential future dilution.
Key Takeaways
The 2023 Equity Incentive Plan's maximum share reserve is raised to 1,250,000 shares of common stock, subject to shareholder approval at the next annual meeting.
The plan adds an automatic annual increase each fiscal year beginning May 1, 2026, equal to the lesser of 25% of total common and as-converted preferred shares outstanding or a lower amount set by the
3 more takeaways
Related Filings (14)
14 more filings from HeartSciences Inc. in the last 90 days
Filing Overview
What This Means
HeartSciences Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.